Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

Background In the 2008 World Health Organization classification, small lymphocytic lymphoma is defined as a neoplasm with the tissue morphology and immunophenotype of chronic lymphocytic leukemia, but with absence of leukemia. Minimal criteria of tissue involvement to separate small lymphocytic lymp...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Sarah E. Gibson, Steven H. Swerdlow, Judith A. Ferry, Urvashi Surti, Paola Dal Cin, Nancy Lee Harris, Robert P. Hasserjian
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Ferrata Storti Foundation 2011-08-01
Sarja:Haematologica
Linkit:https://haematologica.org/article/view/6041
_version_ 1827217453255491584
author Sarah E. Gibson
Steven H. Swerdlow
Judith A. Ferry
Urvashi Surti
Paola Dal Cin
Nancy Lee Harris
Robert P. Hasserjian
author_facet Sarah E. Gibson
Steven H. Swerdlow
Judith A. Ferry
Urvashi Surti
Paola Dal Cin
Nancy Lee Harris
Robert P. Hasserjian
author_sort Sarah E. Gibson
collection DOAJ
description Background In the 2008 World Health Organization classification, small lymphocytic lymphoma is defined as a neoplasm with the tissue morphology and immunophenotype of chronic lymphocytic leukemia, but with absence of leukemia. Minimal criteria of tissue involvement to separate small lymphocytic lymphoma from monoclonal B-cell lymphocytosis have not been defined.Design and Methods We reviewed the clinicopathological features of 36 patients with extramedullary tissue biopsies containing chronic lymphocytic leukemia-type cells and less than 5×109/L peripheral blood monoclonal B cells. Pathological features (extent and patterns of involvement, architectural preservation, presence of proliferation centers) as well as cytogenetic and radiological findings were examined in relation to clinical outcome.Results The biopsies were performed to evaluate lymphadenopathy in 20 patients and for other reasons (most frequently staging of a non-hematologic neoplasm) in 16 patients. At latest follow-up (median 23 months), 21 untreated patients had no or stable lymphadenopathy, 3 had regressed lymphadenopathy, and 12 had developed progressive lymphadenopathy and/or received therapy for chronic lymphocytic leukemia/small lymphocytic lymphoma. Features associated with progression/treatment included lymph nodes 1.5 cm or greater on imaging studies (P=0.01) and presence of proliferation centers in the biopsied tissue (P=0.004). Neither the size nor extent of involvement of the excised lymph node correlated with progression/treatment.Conclusions Our findings suggest that biopsies containing chronic lymphocytic leukemia-type cells, but lacking proliferation centers and with non-enlarged or only slightly enlarged lymph nodes on imaging, represent a very indolent disease that may best be considered a tissue equivalent of monoclonal B-cell lymphocytosis rather than overt small lymphocytic lymphoma. We propose that such cases be designated as tissue involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma-like cells of uncertain significance.
first_indexed 2025-03-21T15:19:15Z
format Article
id doaj.art-4a53f6f91c6f40d19694a7cd45d15b14
institution Directory Open Access Journal
issn 0390-6078
1592-8721
language English
last_indexed 2025-03-21T15:19:15Z
publishDate 2011-08-01
publisher Ferrata Storti Foundation
record_format Article
series Haematologica
spelling doaj.art-4a53f6f91c6f40d19694a7cd45d15b142024-06-19T20:16:33ZengFerrata Storti FoundationHaematologica0390-60781592-87212011-08-0196810.3324/haematol.2011.042333Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosisSarah E. GibsonSteven H. SwerdlowJudith A. FerryUrvashi SurtiPaola Dal CinNancy Lee HarrisRobert P. HasserjianBackground In the 2008 World Health Organization classification, small lymphocytic lymphoma is defined as a neoplasm with the tissue morphology and immunophenotype of chronic lymphocytic leukemia, but with absence of leukemia. Minimal criteria of tissue involvement to separate small lymphocytic lymphoma from monoclonal B-cell lymphocytosis have not been defined.Design and Methods We reviewed the clinicopathological features of 36 patients with extramedullary tissue biopsies containing chronic lymphocytic leukemia-type cells and less than 5×109/L peripheral blood monoclonal B cells. Pathological features (extent and patterns of involvement, architectural preservation, presence of proliferation centers) as well as cytogenetic and radiological findings were examined in relation to clinical outcome.Results The biopsies were performed to evaluate lymphadenopathy in 20 patients and for other reasons (most frequently staging of a non-hematologic neoplasm) in 16 patients. At latest follow-up (median 23 months), 21 untreated patients had no or stable lymphadenopathy, 3 had regressed lymphadenopathy, and 12 had developed progressive lymphadenopathy and/or received therapy for chronic lymphocytic leukemia/small lymphocytic lymphoma. Features associated with progression/treatment included lymph nodes 1.5 cm or greater on imaging studies (P=0.01) and presence of proliferation centers in the biopsied tissue (P=0.004). Neither the size nor extent of involvement of the excised lymph node correlated with progression/treatment.Conclusions Our findings suggest that biopsies containing chronic lymphocytic leukemia-type cells, but lacking proliferation centers and with non-enlarged or only slightly enlarged lymph nodes on imaging, represent a very indolent disease that may best be considered a tissue equivalent of monoclonal B-cell lymphocytosis rather than overt small lymphocytic lymphoma. We propose that such cases be designated as tissue involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma-like cells of uncertain significance.https://haematologica.org/article/view/6041
spellingShingle Sarah E. Gibson
Steven H. Swerdlow
Judith A. Ferry
Urvashi Surti
Paola Dal Cin
Nancy Lee Harris
Robert P. Hasserjian
Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis
Haematologica
title Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis
title_full Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis
title_fullStr Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis
title_full_unstemmed Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis
title_short Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis
title_sort reassessment of small lymphocytic lymphoma in the era of monoclonal b cell lymphocytosis
url https://haematologica.org/article/view/6041
work_keys_str_mv AT sarahegibson reassessmentofsmalllymphocyticlymphomaintheeraofmonoclonalbcelllymphocytosis
AT stevenhswerdlow reassessmentofsmalllymphocyticlymphomaintheeraofmonoclonalbcelllymphocytosis
AT judithaferry reassessmentofsmalllymphocyticlymphomaintheeraofmonoclonalbcelllymphocytosis
AT urvashisurti reassessmentofsmalllymphocyticlymphomaintheeraofmonoclonalbcelllymphocytosis
AT paoladalcin reassessmentofsmalllymphocyticlymphomaintheeraofmonoclonalbcelllymphocytosis
AT nancyleeharris reassessmentofsmalllymphocyticlymphomaintheeraofmonoclonalbcelllymphocytosis
AT robertphasserjian reassessmentofsmalllymphocyticlymphomaintheeraofmonoclonalbcelllymphocytosis